C1orf204 Inhibitors
The chemical class of C1orf204 inhibitors comprises a diverse array of compounds that target key signaling pathways implicated in cellular processes regulated by C1orf204. One significant group of inhibitors includes those that target phosphoinositide 3-kinases (PI3Ks), such as Wortmannin and LY294002. PI3Ks play crucial roles in cell growth, proliferation, and survival by regulating downstream signaling cascades, and their inhibition indirectly affects C1orf204-mediated pathways.
Another class of inhibitors comprises compounds that target mitogen-activated protein kinases (MAPKs), such as U0126, SB203580, SP600125, and PD98059. MAPKs, including ERK1/2, p38 MAPK, and JNK, regulate various cellular processes involved in cell proliferation, differentiation, and apoptosis. Inhibition of these kinases disrupts signaling pathways intersecting with C1orf204 function, potentially modulating its activity.
Overall, C1orf204 inhibitors encompass a range of compounds that target critical signaling pathways, offering valuable tools for investigating the functional roles of C1orf204 and its involvement in cellular processes. These inhibitors provide insights into the complex regulatory networks governing cellular functions and represent potential candidates for further exploration in research aimed at understanding the physiological and pathological roles of C1orf204.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin inhibits phosphoinositide 3-kinases (PI3Ks), which play a role in various cellular processes, including cell growth, proliferation, and survival. By blocking PI3K activity, wortmannin can indirectly inhibit C1orf204-mediated signaling pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a potent inhibitor of phosphoinositide 3-kinases (PI3Ks), similar to wortmannin. Its inhibition of PI3Ks disrupts downstream signaling pathways implicated in cell survival and proliferation, potentially influencing C1orf204-mediated cellular processes. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
U0126 inhibits MEK1 and MEK2, which are upstream activators of ERK1/2 signaling. By blocking MEK activity, U0126 disrupts the ERK1/2 pathway, which is involved in regulating various cellular processes, including cell growth and differentiation, potentially impacting C1orf204 function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 is a selective inhibitor of p38 mitogen-activated protein kinase (MAPK), which regulates cellular responses to stress and inflammation. Inhibition of p38 MAPK by SB203580 can affect downstream signaling pathways involved in cell proliferation and differentiation, influencing C1orf204-mediated processes. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits c-Jun N-terminal kinases (JNKs), which are members of the MAPK family involved in regulating cell growth, apoptosis, and inflammatory responses. By blocking JNK activity, SP600125 can modulate signaling pathways associated with C1orf204 function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 inhibits MEK1 and MEK2, upstream kinases in the ERK1/2 signaling pathway. Disruption of ERK1/2 activation by PD98059 can impact downstream cellular processes, including cell proliferation and differentiation, potentially affecting C1orf204-mediated pathways. | ||||||